Insilico, which uses AI to accelerate drug discovery, says early data shows that rentosertib, a drug developed to treat a chronic lung disease, could slow aging
THE SO WHAT
If AI-designed drugs like rentosertib show credible aging effects on top of a primary indication, the upside case for AI-first biotech shifts from faster pipelines to entirely new therapeutic categories. Operators in healthcare need to assume regulators, payers, and ethics boards will become as central a constraint as wet-lab throughput.
READ THE SOURCE
MORE FROM THE WIRE
Deep & Emerging TechHackers are using 'invisible' Unicode characters to sneak phishing lures into emails
Prompt-injection style Unicode tricks leaking into email phishing means your existing filters and user training are already behind. Security teams should update detection rules for control characters and test how their own AI email summarizers handle adversarial Unicode this week.
Deep & Emerging TechInsilico says its AI-designed lung drug lowered biological age markers in a 42-patient trial
An AI-designed lung drug that makes patients look biologically younger across six independent aging clocks is an early but concrete datapoint that AI can touch not just disease but systemic aging markers. Biotech and pharma teams should be reassessing where in their pipelines AI-first discovery could justify new trials, even at small initial scales.
Deep & Emerging TechTech companies are scouting Argentine Patagonia for AI data centres, Reuters reports
Hyperscalers scouting Patagonia for AI data centers shows the search for cheap power and cool climates is pushing infra into new geographies. If you depend on large-scale training or inference, start mapping political, grid, and connectivity risk alongside raw megawatt pricing when you evaluate future sites.
Deep & Emerging TechGuest Post: QML4Africa Highlights Growth of Africa’s Quantum Research Community
QML4Africa’s growth shows quantum talent and research are globalizing even if hardware isn’t. If you’re planning long-term bets in quantum or advanced computing, start treating African universities and consortia as real partners in the pipeline, not just outreach targets.